1. Crossing the blood-brain-barrier with nanoligand drug carriers self-assembled from a phage display peptide
- Author
-
Lin-Ping Wu, Arnaldur Hall, Junan Su, Xiaolong Tan, S. Moein Moghimi, Z. Shadi Farhangrazi, and Davoud Ahmadvand
- Subjects
0301 basic medicine ,Phage display ,Science ,General Physics and Astronomy ,Transferrin receptor ,Peptide ,02 engineering and technology ,Ligands ,Microscopy, Atomic Force ,Article ,General Biochemistry, Genetics and Molecular Biology ,03 medical and health sciences ,Drug Delivery Systems ,Microscopy, Electron, Transmission ,Peptide Library ,Nanoscience and technology ,Animals ,Receptor ,Peptide library ,lcsh:Science ,chemistry.chemical_classification ,Drug Carriers ,Multidisciplinary ,biology ,Chemistry ,Health care ,General Chemistry ,021001 nanoscience & nanotechnology ,biology.organism_classification ,Chemical biology ,Filamentous bacteriophage fd ,Cell biology ,030104 developmental biology ,Blood-Brain Barrier ,Nanoparticles ,lcsh:Q ,Nanocarriers ,0210 nano-technology ,Drug carrier ,Bacteriophage M13 ,Biotechnology - Abstract
The filamentous bacteriophage fd bind a cell target with exquisite specificity through its few copies of display peptides, whereas nanoparticles functionalized with hundreds to thousands of synthetically generated phage display peptides exhibit variable and often-weak target binding. We hypothesise that some phage peptides in a hierarchical structure rather than in monomeric form recognise and bind their target. Here we show hierarchial forms of a brain-specific phage-derived peptide (herein as NanoLigand Carriers, NLCs) target cerebral endothelial cells through transferrin receptor and the receptor for advanced glycation-end products, cross the blood-brain-barrier and reach neurons and microglial cells. Through intravenous delivery of NLC-β-secretase 1 (BACE1) siRNA complexes we show effective BACE1 down-regulation in the brain without toxicity and inflammation. Therefore, NLCs act as safe multifunctional nanocarriers, overcome efficacy and specificity limitations in active targeting with nanoparticles bearing phage display peptides or cell-penetrating peptides and expand the receptor repertoire of the display peptide., Bacteriophages can bind targets with only a few copies of a display peptide while most nanoparticles with thousands achieve poor binding. Here the authors form hierarchical arrangements of phage peptides to delivery siRNA across the blood brain barrier.
- Published
- 2019
- Full Text
- View/download PDF